Correspondence 0001213900-24-110727 from Jabez Biosciences, Inc. (CIK 0002038185)
Jabez Biosciences, Inc. (CIK 0002038185)
Date: Dec. 20, 2024 · CIK: 0002038185 · Accession: 0001213900-24-110727
AI Filing Summary & Sentiment
File numbers found in text: 024-12509
Letter
United States Securities and Exchange Commission Office of Life Sciences Offering Statement on Form 1-A Filed September 21, 2024 File No. 024-12509 RE: Request for Qualification of Form 1-A, originally filed September 21, 2024 as amended by Form 1-AA on December 12, 2024.
Dear Mr. Gorsky and Mses. Gama, Torney and Mast,
Jabez Biosciences, Inc. hereby requests qualification of the above referenced Form 1-A (as amended by Form 1-A/A) on or before noon on December 23, 2024, or as soon as practical thereafter.
In making this request, the Company acknowledges that:
● Should the Commission or the staff, acting pursuant to delegated authority, qualify the filing, it does not foreclose the Commission from taking any action with respect to the filing;
● The action of the Commission or the staff, acting pursuant to delegated authority, in qualifying the filing, does not relieve the Company from its full responsibility from the adequacy and accuracy of the disclosure in the filing; and
● The Company may not assert staff comments and/or qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Respectfully Submitted,
/s/ Tamara Jovonovich
Show Raw Text
CORRESP
1
filename1.htm
JABEZ BIOSCIENCES, INC.
6393 Blackstone Dr.
Zionsville, IN 46077
December 20, 2024
Doris Stacey Gama
Joshua Gorsky
Christine Torney
Mary Mast
United States Securities and Exchange Commission
Office of Life Sciences
Washington, DC
Re:
Jabez Biosciences, Inc.
Offering Statement on Form 1-A
Filed September 21, 2024
File No. 024-12509
RE: Request for Qualification of Form 1-A, originally filed September
21, 2024 as amended by Form 1-AA on December 12, 2024.
Dear Mr. Gorsky and Mses. Gama, Torney and Mast,
Jabez Biosciences, Inc. hereby
requests qualification of the above referenced Form 1-A (as amended by Form 1-A/A) on or before noon on December 23, 2024, or as soon
as practical thereafter.
In making this request, the Company acknowledges
that:
● Should the Commission or the staff, acting pursuant to delegated
authority, qualify the filing, it does not foreclose the Commission from taking any action with respect to the filing;
● The action of the Commission or the staff, acting pursuant
to delegated authority, in qualifying the filing, does not relieve the Company from its full responsibility from the adequacy and accuracy
of the disclosure in the filing; and
● The Company may not assert staff comments and/or qualification
as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Respectfully Submitted,
/s/ Tamara Jovonovich
Tamara Jovonovich, President